Nedira Salzman-Frenkel.
Corporate Officer/Principal at NEUROSENSE THERAPEUTICS LTD.
Profile
Nedira Salzman-Frenkel is currently the Vice President-Business Development at Neurosense Therapeutics Ltd.
Previously, she served as the Chief Executive Officer at Radikal Therapeutics, Inc. from 2017 to 2021.
Ms. Salzman-Frenkel holds a graduate degree from The Hebrew University of Jerusalem, an undergraduate degree from Ben-Gurion University of the Negev, and an MBA from Recanati School of Business Administration.
Nedira Salzman-Frenkel. active positions
| Companies | Position | Start |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Corporate Officer/Principal | 2022-02-28 |
Former positions of Nedira Salzman-Frenkel.
| Companies | Position | End |
|---|---|---|
Radikal Therapeutics, Inc.
 Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Chief Executive Officer | 2021-09-30 |
Training of Nedira Salzman-Frenkel.
| Ben-Gurion University of the Negev | Undergraduate Degree |
| The Hebrew University of Jerusalem | Graduate Degree |
| Recanati School of Business Administration | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Commercial Services |
- Stock Market
- Insiders
- Nedira Salzman-Frenkel.
